Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-19
1997-01-07
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514448, 514461, 546314, 546315, 546318, 546326, 549 71, 549 72, 549484, 549486, 549488, A61K 3144, A61K 3134, C07D21379, C07D30768
Patent
active
055917569
ABSTRACT:
This invention relates to a compound of the formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein X is oxygen, sulfur, --CH.dbd.CH--, or --CH.dbd.N--;
REFERENCES:
patent: 2594355 (1950-04-01), Schwenk et al.
patent: 3255241 (1966-06-01), Schultz et al.
patent: 3912656 (1975-10-01), Andrews et al.
patent: 3919250 (1975-11-01), Pauling et al.
patent: 4015010 (1977-03-01), Houlihan et al.
patent: 4381360 (1983-04-01), Leistner et al.
patent: 4469885 (1984-09-01), Mueller et al.
patent: 4752324 (1988-06-01), Thomas et al.
Fackler, Progress Inorg. Chem., "Metal .beta.-Ketoenolate Complexes" pp. 361-425 (1966).
Singh, et al., Progress in Medicinal Chem., vol. 17, Elseveer, Chap. 4--Medicinal Chem. of Tetrazoles, pp. 151-183 (1980).
Thornber, Chem. Society Reviews, vol. 8, pp. 563-580 (1979).
Ercoli et. al., J. Org. Chem., vol. 32, pp. 2917-2918 (1967).
Chem. Abstracts, vol. 104:129724 (1985); Struharik et. al., Chem. Pap., 39(3), pp. 391-400 (1985).
Djuric Stevan W.
Haack Richard A.
Miyashiro Julie M.
Dentz Bernard
G. D. Searle & Co.
LandOfFree
LTB4 synthesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with LTB4 synthesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LTB4 synthesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764567